NO822932L - Analogifremgangsmaate for fremstilling av heterocykliske benzoforbindelser. - Google Patents

Analogifremgangsmaate for fremstilling av heterocykliske benzoforbindelser.

Info

Publication number
NO822932L
NO822932L NO822932A NO822932A NO822932L NO 822932 L NO822932 L NO 822932L NO 822932 A NO822932 A NO 822932A NO 822932 A NO822932 A NO 822932A NO 822932 L NO822932 L NO 822932L
Authority
NO
Norway
Prior art keywords
preparation
analogue procedure
benzo compounds
heterocyclic benzo
heterocyclic
Prior art date
Application number
NO822932A
Other languages
English (en)
Other versions
NO157738B (no
NO157738C (no
Inventor
Kurt Schromm
Anton Mentrup
Ernst-Otto Renth
Armin Fuegner
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO822932L publication Critical patent/NO822932L/no
Publication of NO157738B publication Critical patent/NO157738B/no
Publication of NO157738C publication Critical patent/NO157738C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO822932A 1981-09-01 1982-08-31 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazinoner og benzoksazolinoner. NO157738C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813134590 DE3134590A1 (de) 1981-09-01 1981-09-01 Neue benzo-heterocyclen

Publications (3)

Publication Number Publication Date
NO822932L true NO822932L (no) 1983-03-02
NO157738B NO157738B (no) 1988-02-01
NO157738C NO157738C (no) 1988-05-11

Family

ID=6140603

Family Applications (1)

Application Number Title Priority Date Filing Date
NO822932A NO157738C (no) 1981-09-01 1982-08-31 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazinoner og benzoksazolinoner.

Country Status (25)

Country Link
EP (1) EP0073505B1 (no)
JP (1) JPS5852278A (no)
KR (1) KR890000380B1 (no)
AR (2) AR231976A1 (no)
AT (1) ATE16703T1 (no)
AU (1) AU553589B2 (no)
CA (1) CA1180012A (no)
CS (1) CS236679B2 (no)
DD (1) DD204477A5 (no)
DE (2) DE3134590A1 (no)
DK (1) DK158664C (no)
ES (3) ES8308318A1 (no)
FI (1) FI78475C (no)
GB (1) GB2106105B (no)
GR (1) GR77275B (no)
HU (1) HU186112B (no)
IE (1) IE53615B1 (no)
IL (1) IL66683A0 (no)
NO (1) NO157738C (no)
NZ (1) NZ201777A (no)
PL (1) PL139375B1 (no)
PT (1) PT75478A (no)
SU (1) SU1149876A3 (no)
YU (1) YU42794B (no)
ZA (1) ZA826349B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554284A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
DE3743265A1 (de) * 1987-12-19 1989-06-29 Boehringer Ingelheim Kg Neue ammoniumverbindungen, ihre herstellung und verwendung
TW372967B (en) * 1994-12-27 1999-11-01 Kanebo Ltd 1,4 benzoxazine derivative, pharmaceutical composition containing the same and use thereof
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
PE20040950A1 (es) 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
EP1613315B1 (en) * 2003-04-04 2009-01-21 Novartis AG Quinoline-2-one-derivatives for the treatment of airways diseases
GB0307856D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Organic compounds
US7307076B2 (en) 2004-05-13 2007-12-11 Boehringer Ingelheim International Gmbh Beta agonists for the treatment of respiratory diseases
JP2007537187A (ja) * 2004-05-13 2007-12-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器疾患の治療においてβアゴニストとして使用するためのヒドロキシ置換ベンゾ縮合ヘテロ環化合物
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
DE102004024453A1 (de) * 2004-05-14 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Bronchodilatoren zur Behandlung von Atemwegserkrankungen
DE102004024454A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024451A1 (de) * 2004-05-14 2005-12-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierungen für die Inhalation, die Enantiomerenreine Betaagonisten enthalten
US7745621B2 (en) 2004-05-14 2010-06-29 Boehringer Ingelheim International Gmbh Long acting bronchodilators for the treatment of respiratory diseases
JP5270343B2 (ja) 2005-08-15 2013-08-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ベータミメティックスの製造方法
US20070088030A1 (en) * 2005-10-10 2007-04-19 Barbara Niklaus-Humke Aerosol formulations for the inhalation of beta-agonists
GB0602778D0 (en) 2006-02-10 2006-03-22 Glaxo Group Ltd Novel compound
WO2008017638A1 (de) * 2006-08-07 2008-02-14 Boehringer Ingelheim International Gmbh Enantiomerenreine betaagonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
PL2125759T3 (pl) * 2007-01-25 2011-12-30 Boehringer Ingelheim Int Sposób wytwarzania związków betamimetycznych

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2035749A1 (no) * 1969-02-06 1970-12-24 Bellon Labor Sa Roger
DE2429253A1 (de) * 1974-06-19 1976-01-15 Boehringer Sohn Ingelheim Phenylalkanolamine

Also Published As

Publication number Publication date
NZ201777A (en) 1985-08-30
DK158664C (da) 1991-01-14
AU553589B2 (en) 1986-07-24
JPH035392B2 (no) 1991-01-25
ES515380A0 (es) 1983-08-16
DK389082A (da) 1983-03-02
DE3267702D1 (en) 1986-01-09
DD204477A5 (de) 1983-11-30
GR77275B (no) 1984-09-11
YU194982A (en) 1984-12-31
AU8787482A (en) 1983-03-10
PT75478A (en) 1982-09-01
NO157738B (no) 1988-02-01
FI822985A0 (fi) 1982-08-30
KR890000380B1 (ko) 1989-03-15
PL139375B1 (en) 1987-01-31
FI78475B (fi) 1989-04-28
ZA826349B (en) 1984-04-25
GB2106105B (en) 1985-07-10
IE822105L (en) 1983-03-01
YU42794B (en) 1988-12-31
PL238077A1 (en) 1984-04-09
KR840001560A (ko) 1984-05-07
NO157738C (no) 1988-05-11
CS236679B2 (en) 1985-05-15
JPS5852278A (ja) 1983-03-28
AR231976A1 (es) 1985-04-30
ES521871A0 (es) 1984-06-16
EP0073505B1 (de) 1985-11-27
DK158664B (da) 1990-07-02
ES8308318A1 (es) 1983-08-16
FI822985L (fi) 1983-03-02
GB2106105A (en) 1983-04-07
SU1149876A3 (en) 1985-04-07
HU186112B (en) 1985-06-28
ES521870A0 (es) 1984-01-16
CA1180012A (en) 1984-12-27
ES8405778A1 (es) 1984-06-16
DE3134590A1 (de) 1983-03-10
AR231977A1 (es) 1985-04-30
FI78475C (fi) 1989-08-10
IL66683A0 (en) 1982-12-31
EP0073505A1 (de) 1983-03-09
IE53615B1 (en) 1988-12-21
ATE16703T1 (de) 1985-12-15
ES8402279A1 (es) 1984-01-16

Similar Documents

Publication Publication Date Title
NO821087L (no) Fremgangsmaate for fremstilling av cyklobutan-derivater.
NO822932L (no) Analogifremgangsmaate for fremstilling av heterocykliske benzoforbindelser.
NO811731L (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater
NO813678L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
NO162073C (no) Analogifremgangsmaate for fremstilling av farmakologiske aktive heterocykliske forbindelser.
NO912411D0 (no) Fremgangsmaate for fremstilling av bicykliske heterocykliske forbindelser.
NO152904C (no) Analogifremgangsmaate til fremstilling av farmakologisk virksomme heksapyranoseforbindelser.
NO905008L (no) Fremgangsmaate for fremstilling av heterocykliske forbindelser.
NO822538L (no) Fremgangsmaate for fremstilling av antibakterielle beta-laktam-derivater.
NO157861C (no) Analogifremgangsmaate til fremstilling av aminopyridaziner.
NO820959L (no) Fremgangsmaate til fremstilling av acyl-kinolinonderivater
NO161066C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive kinolinderivater.
NO155693C (no) Fremgangsmaate for fremstilling av eburnamoninderivater.
NO822634L (no) Fremgangsmaate for fremstilling av cefemderivater.
NO149958C (no) Analogifremgangsmaate til fremstilling av cykloheksenderivater
NO156086C (no) Analogifremgangsmaate for fremstilling av substituerte heterocykliske fenoksyaminer.
NO156865C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO813477L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
NO164772C (no) Fremgangsmaate for fremstilling av cefalosporinderivater.
NO157143C (no) Fremgangsmaate for fremstilling av karbapen-2-em-derivater.
NO157736C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO154636C (no) Fremgangsmaate til fremstilling av krystallinske aminocyklitolderivater.
NO158736C (no) Analogifremgangsmaate for fremstilling av tetrahydropyridinderivater.
NO812842L (no) Fremgangsmaate for fremstilling av aminoacetonitil-derivater
ES517428A0 (es) Procedimiento de preparacion de derivados bencilidenicos.